Product

MEI6570

1 clinical trial

3 indications

Indication
Type 2
Clinical trial
REducing Diabetic macrovascUlar Complications duE to Peripheral Arterial Disease- REDUCE-PAD
Status: Not yet recruiting, Estimated PCD: 2025-09-01